Soligenix, Inc.
Research Soligenix, Inc. (0A6I) with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- Ticker0A6I
- ExchangeLSE
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
About Soligenix, Inc.
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a photodynamic therapy, which has completed Phase 3 clinical trial for the treatment of cutaneous T-cell lymphoma;
Frequently asked questions
What does Soligenix, Inc. do?
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions.